Risperidone ODT 1mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication with or without food, as directed. Continue taking it as prescribed by your doctor or healthcare provider, even if you're feeling well.
When taking your medication, make sure to:
Remove it from the blister pack only when you're ready to take it
Take it immediately after opening the blister pack
Do not store the removed medication for future use
Use dry hands to remove the tablet from the foil
Place the tablet on your tongue and let it dissolve; water is not necessary
Do not swallow the tablet whole, chew, break, or crush it
Storing and Disposing of Your Medication
To store your medication properly:
Keep it at room temperature, protected from light
Store it in a dry place, away from the bathroom
Keep all medications in a safe location, out of the reach of children and pets
When disposing of your medication:
Throw away any unused or expired medication
Do not flush it down the toilet or pour it down the drain unless instructed to do so
Check with your pharmacist for guidance on the best way to dispose of your medication
* Consider participating in a drug take-back program in your area, if available
Missing a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and return to your regular schedule. Do not take two doses at the same time or take extra doses.
Lifestyle & Tips
- Take exactly as prescribed, do not stop abruptly without consulting your doctor.
- Avoid alcohol and other CNS depressants as they can increase drowsiness.
- Be aware of potential dizziness or lightheadedness, especially when standing up quickly. Rise slowly.
- Monitor for weight gain and try to maintain a healthy diet and exercise routine.
- Report any unusual muscle movements (tremors, stiffness, restlessness) or changes in menstrual cycle/breast discharge.
- Stay hydrated, especially in hot weather, as this medication can affect body temperature regulation.
Available Forms & Alternatives
Available Strengths:
- Risperidone ODT 0.25mg Tablets
- Risperidone 1mg/ml Oral Soln 30ml
- Risperidone ODT 2mg Tablets
- Risperidone ODT 0.5mg Tablets
- Risperidone 0.5mg Tablets
- Risperidone 3mg Tablets
- Risperidone 4mg ODT Tablets
- Risperidone 1mg Tablets
- Risperidone 0.25mg Tablets
- Risperidone 2mg Tablets
- Risperidone 4mg Tablets
- Risperidone ODT 3mg Tablets
- Risperidone ODT 1mg Tablets
- Risperidone ER 25mg Inj Susp Kit
- Risperidone ER 50mg Inj Susp Kit
- Risperidone ER 37.5mg Inj Susp Kit
- Risperidone ER 12.5mg Inj, 1 Vial
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Severe dizziness or fainting
Changes in behavior or mood
Shakiness, difficulty moving, or stiffness
Urination problems ( inability to pass urine or changes in urine output)
Trouble swallowing or speaking
Difficulty focusing
Seizures
Changes in vision
Shortness of breath
Drooling
Feeling extremely hot or cold
Hormonal changes, such as:
+ Enlarged breasts
+ Nipple discharge
+ Erectile dysfunction or changes in menstrual cycle
Sexual problems, including:
+ Decreased libido
+ Ejaculation problems
Prolonged or painful erections (lasting more than 4 hours), which can lead to permanent sexual dysfunction if left untreated
Neuroleptic malignant syndrome (NMS), a rare but potentially life-threatening condition, characterized by:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking or mental status
+ Rapid heartbeat
+ Abnormal heartbeat
+ Excessive sweating
Low white blood cell count, which can increase the risk of infection; if you have a history of low white blood cell count, inform your doctor and seek medical attention if you experience:
+ Fever
+ Chills
+ Sore throat
Tardive dyskinesia, a severe muscle disorder, which may cause:
+ Uncontrolled body movements
+ Tongue, face, mouth, or jaw problems (such as tongue sticking out, puffing cheeks, mouth puckering, or chewing)
Other Possible Side Effects
While many people may not experience any side effects or only minor ones, it's essential to be aware of the following potential side effects:
Weight gain
Restlessness
Dizziness, drowsiness, tiredness, or weakness
Anxiety
Gastrointestinal problems (constipation, diarrhea, stomach pain, upset stomach, or vomiting)
Heartburn
Dry mouth
Changes in appetite
Common cold symptoms
Headache
Sleep disturbances
* Back, muscle, arm, or leg pain
If you experience any of these side effects or have concerns, contact your doctor or seek medical attention. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Fever, muscle stiffness, confusion, sweating, fast or irregular heartbeat (Neuroleptic Malignant Syndrome - NMS)
- Uncontrolled muscle movements of the face, tongue, or other body parts (Tardive Dyskinesia)
- Severe dizziness or fainting
- Difficulty swallowing or breathing
- Seizures
- Signs of high blood sugar (increased thirst, increased urination, hunger, weakness)
- Prolonged or painful erection (priapism)
- Signs of allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
Potential interactions with other medications or health conditions. This medication may affect or be affected by other drugs or health problems, so it is crucial to disclose all relevant information.
To ensure safe use, provide your doctor and pharmacist with a comprehensive list of:
All prescription and over-the-counter (OTC) medications you are taking
Natural products and vitamins you are using
* Any health problems you have
Carefully review your medications and health conditions to confirm that it is safe to take this medication in conjunction with them. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
Inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
Precautions to Ensure Your Safety
Avoid driving and engaging in activities that require alertness until you understand how this medication affects you. To minimize the risk of dizziness or fainting, stand up slowly after sitting or lying down, and be cautious when climbing stairs.
Potential Effects and Monitoring
It may take several weeks to experience the full effects of this medication. Be aware that medications like this one can increase the risk of high blood sugar, diabetes, high cholesterol, and weight gain, which may contribute to heart and brain blood vessel disease. Monitor your blood sugar levels as directed by your doctor, and undergo regular blood tests as advised by your doctor.
Substance Interactions and Precautions
Avoid consuming alcohol while taking this medication. Before using marijuana, cannabis, or prescription or over-the-counter medications that may cause drowsiness, consult with your doctor. In hot weather or during physical activity, drink plenty of fluids to prevent dehydration.
Potential Side Effects and Risks
This medication may cause dizziness, drowsiness, and impaired balance, which can increase the risk of falls and related injuries. If you have phenylketonuria (PKU), consult with your doctor, as some products contain phenylalanine.
Special Considerations for Older Adults
Older adults with dementia who take medications like this one have a higher risk of stroke, which can be fatal. This medication is not approved for treating dementia-related mental health issues. If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
Pregnancy, Fertility, and Breastfeeding
This medication may affect fertility, but this effect is reversible when the medication is discontinued. If you have questions or concerns, discuss them with your doctor. Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding, as you will need to weigh the benefits and risks to you and your baby. Taking this medication during the third trimester of pregnancy may cause side effects or withdrawal symptoms in the newborn.
Overdose Information
Overdose Symptoms:
- Drowsiness
- Sedation
- Tachycardia (fast heart rate)
- Hypotension (low blood pressure)
- Extrapyramidal symptoms (tremors, muscle stiffness, involuntary movements)
- QTc prolongation
- Seizures
What to Do:
Call 911 or Poison Control (1-800-222-1222) immediately. Seek emergency medical attention. Treatment is supportive, including maintaining airway, oxygenation, and ventilation. Gastric lavage and activated charcoal may be considered. Monitor cardiovascular function, including ECG, and treat hypotension and arrhythmias as needed. Do not induce vomiting.
Drug Interactions
Major Interactions
- CNS depressants (e.g., opioids, benzodiazepines, alcohol): Increased sedation.
- QTc-prolonging drugs (e.g., Class IA and III antiarrhythmics, moxifloxacin, thioridazine): Increased risk of arrhythmias.
- Dopamine agonists (e.g., levodopa, bromocriptine): Antagonism of effects.
- Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine): Significantly increase risperidone plasma levels.
- Strong CYP3A4 inducers (e.g., carbamazepine, rifampin, phenytoin): Significantly decrease risperidone plasma levels.
Moderate Interactions
- Antihypertensives: Additive hypotensive effects.
- Diuretics (especially in elderly with dementia): Increased risk of orthostatic hypotension and dehydration.
- Drugs causing electrolyte imbalance (e.g., hypokalemia, hypomagnesemia): Increased risk of QTc prolongation.
- Valproate: Increased risperidone levels (mechanism unclear, possibly displacement from protein binding).
Minor Interactions
- Cimetidine, ranitidine: Minor increase in risperidone levels.
- Clozapine: May increase risperidone levels.
Monitoring
Baseline Monitoring
Rationale: Risk of weight gain and metabolic syndrome.
Timing: Before initiation
Rationale: Risk of hyperglycemia and new-onset diabetes.
Timing: Before initiation
Rationale: Risk of dyslipidemia.
Timing: Before initiation
Rationale: Risk of orthostatic hypotension.
Timing: Before initiation
Rationale: Assess for baseline QTc prolongation, especially if risk factors present (cardiac disease, family history of sudden death, other QTc-prolonging drugs).
Timing: Before initiation (if indicated)
Rationale: Risk of hyperprolactinemia (galactorrhea, amenorrhea, gynecomastia, sexual dysfunction).
Timing: Before initiation (if indicated or symptomatic)
Rationale: Assess for baseline dyskinesia.
Timing: Before initiation
Routine Monitoring
Frequency: Monthly for first few months, then quarterly.
Target: Stable weight, healthy BMI.
Action Threshold: Significant weight gain (e.g., >5% baseline) warrants intervention.
Frequency: At 3 months, then annually.
Target: Normal glucose/HbA1c.
Action Threshold: Elevated levels require further evaluation and management.
Frequency: At 3 months, then annually.
Target: Normal lipid profile.
Action Threshold: Elevated levels require further evaluation and management.
Frequency: Weekly during titration, then periodically.
Target: Stable blood pressure.
Action Threshold: Significant orthostatic drop (e.g., >20 mmHg systolic, >10 mmHg diastolic) or symptomatic hypotension.
Frequency: Regularly, especially during dose titration and if symptoms emerge.
Target: Absence of EPS.
Action Threshold: Emergence of EPS (e.g., akathisia, dystonia, parkinsonism, tardive dyskinesia).
Frequency: Periodically if symptomatic (e.g., galactorrhea, amenorrhea, sexual dysfunction) or if long-term use.
Target: Normal prolactin levels.
Action Threshold: Symptomatic hyperprolactinemia.
Frequency: Ongoing.
Target: Improvement in target symptoms, stable mood/thought processes.
Action Threshold: Worsening symptoms, lack of efficacy, or emergence of new psychiatric symptoms.
Symptom Monitoring
- Sedation/drowsiness
- Dizziness/lightheadedness (especially upon standing)
- Muscle stiffness/tremor/restlessness (EPS)
- Weight gain
- Increased thirst/urination (signs of hyperglycemia)
- Changes in menstrual cycle/galactorrhea (hyperprolactinemia)
- Blurred vision
- Constipation
- Dry mouth
- Sexual dysfunction
- Agitation/anxiety (paradoxical effect)
Special Patient Groups
Pregnancy
Category C. Studies in animals have shown adverse effects on the fetus. There are no adequate and well-controlled studies in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to antipsychotic drugs during the third trimester are at risk for extrapyramidal and/or withdrawal symptoms following delivery.
Trimester-Specific Risks:
Lactation
Risperidone and its active metabolite (9-hydroxyrisperidone) are excreted into human milk. The relative infant dose (RID) is estimated to be low (around 1-2%). Monitor the infant for sedation, poor feeding, and developmental milestones. L3 (Moderately Safe).
Pediatric Use
Approved for irritability associated with autistic disorder (5-16 years), schizophrenia (13-17 years), and bipolar mania (10-17 years). Dosing is weight-based for autism and age-based for schizophrenia/bipolar mania. Children and adolescents may be more susceptible to certain side effects like weight gain, hyperprolactinemia, and EPS. Close monitoring is essential.
Geriatric Use
Elderly patients, especially those with dementia-related psychosis, are at increased risk of death when treated with antipsychotics (Black Box Warning). Increased risk of cerebrovascular adverse events (stroke, TIA). More susceptible to orthostatic hypotension and EPS. Start with lower doses and titrate slowly. Monitor for falls, sedation, and metabolic changes.
Clinical Information
Clinical Pearls
- Risperidone ODT can be taken with or without water. Place on the tongue, it will dissolve rapidly.
- The ODT formulation is useful for patients who have difficulty swallowing pills or who may be non-adherent with conventional tablets.
- High doses (>6 mg/day) are associated with a higher risk of EPS and hyperprolactinemia without significant additional efficacy for schizophrenia.
- Monitor for metabolic side effects (weight gain, dyslipidemia, hyperglycemia) regularly, as these are common with atypical antipsychotics.
- Hyperprolactinemia can lead to sexual dysfunction, amenorrhea, galactorrhea, and potentially long-term bone density issues. Consider monitoring prolactin if symptomatic.
- Orthostatic hypotension is common, especially during initial titration. Advise patients to rise slowly and stay hydrated.
- Be vigilant for signs of Neuroleptic Malignant Syndrome (NMS), a rare but potentially fatal adverse reaction.
Alternative Therapies
- Other atypical antipsychotics (e.g., olanzapine, quetiapine, aripiprazole, ziprasidone, lurasidone, cariprazine, brexpiprazole)
- Typical antipsychotics (e.g., haloperidol, chlorpromazine) - generally less preferred due to higher EPS risk.
- Mood stabilizers (e.g., lithium, valproate, lamotrigine) for bipolar disorder.
- SSRIs/SNRIs for mood/anxiety symptoms (if comorbid or primary indication is not psychosis/mania).
- Behavioral therapies and psychosocial interventions.